In this episode of #AskDrDurie, Dr. Brian Durie, IMF Chairman and 
Co-Founder, talks about the Black Swan Research Initiative(R)'s various clinical trials and how eligible patients can get more information and potentially participate in them.
 


Image of Dr. Brian G.M. DurieDr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.

 

Previous Post
#AskDrDurie: Are there maintenance therapy recommendations for myeloma patients with t(4;14)?
Next Post
#AskDrDurie: How does the new flow cytometry testing for MRD compare to molecular testing?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.